StockDuty ← Dashboard Oct 30, 2026 01:25 AM ET
SignalCorporate

ResMed outlines FY 2027 $5.75B-$5.85B revenue outlook while targeting $1.85B+ shareholder returns

ResMed issued FY2027 revenue guidance of $5.75B-$5.85B plus $1.85B+ shareholder returns.

ResMed issued FY2027 revenue guidance of $5.75B-$5.85B plus $1.85B+ shareholder returns.
ResMed issued FY2027 revenue guidance of $5.75B-$5.85B plus $1.85B+ shareholder returns. — impact context not separately stored; see What changed.
Sources